Stock Events

Bausch + Lomb 

$14.59
8
+$0.28+1.96% Tuesday 21:00

Statistics

Day High
14.85
Day Low
14.19
52W High
21.95
52W Low
13.62
Volume
837,796
Avg. Volume
394,180
Mkt Cap
5.12B
P/E Ratio
-24.68
Dividend Yield
-
Dividend
-

Earnings

21FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
0
0.1
0.21
0.31
Expected EPS
0.24
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLCO. It's not an investment recommendation.

Analyst Ratings

17.5$Average Price Target
The highest estimate is $21.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
25%
Hold
75%
Sell
0%

About

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Show more...
CEO
Mr. Joseph C. Papa
Employees
12500
Country
CA
ISIN
CA0717051076
WKN
000A3DLMS

Listings